ID
42287
Descripción
Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer
Palabras clave
Versiones (2)
- 2021-05-04 2021-05-04 -
- 2021-05-04 2021-05-04 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
4 maj 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)
Laboratory Reference Ranges; Concomitant Medication; Adverse Experiences (Non-serious)
Descripción
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Descripción
Investigator
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826892
Descripción
Date for which these reference ranges became effective
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0883335
- UMLS CUI [1,2]
- C0011008
Descripción
Laboratory Name
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3258037
Descripción
Laboratory Address
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1442065
- UMLS CUI [1,2]
- C0022877
Descripción
Reference range gender
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0883335
- UMLS CUI [1,2]
- C0079399
Descripción
Age range
Tipo de datos
text
Unidades de medida
- Years
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1514721
Descripción
Laboratory Reference Ranges
Alias
- UMLS CUI-1
- C0883335
Descripción
Test - Haematology
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0018941
Descripción
Test - Blood Chemistry
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0525044
Descripción
Unit
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519795
Descripción
Low Reference Value
Tipo de datos
float
Alias
- UMLS CUI [1]
- C1272773
Descripción
High Reference Value
Tipo de datos
float
Alias
- UMLS CUI [1]
- C1299400
Descripción
Concomitant Medication - Continued
Alias
- UMLS CUI-1
- C2347852
Descripción
Trade Name Preferred
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2360065
Descripción
(e.g. 500mg)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348070
Descripción
Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Medical Condition
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0012634
Descripción
Medication Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826734
Descripción
Medication End Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826744
Descripción
Medication Continuing
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0549178
Descripción
Adverse Experiences (Non-serious)
Alias
- UMLS CUI-1
- C1518404
Descripción
Adverse Experiences (Non-serious)
Alias
- UMLS CUI-1
- C1518404
Descripción
Adverse Experience
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
Adverse Experience Onset Date and Time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2985916
- UMLS CUI [2]
- C2697889
Descripción
If ongoing please leave blank
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826793
Descripción
If patient died, STOP: go to SAE section and follow instructions given there
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1705586
Descripción
Experience Course
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Descripción
If Intermittent Course, record number of episodes
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0750729
- UMLS CUI [1,2]
- C0205267
- UMLS CUI [1,3]
- C4086638
Descripción
Grade 1 = Mild Grade 2 = Moderate Grade 3 = Severe Grade 4 = Life Threatening
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2826262
Descripción
Action Taken with Respect to Investigational Drug
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2826626
Descripción
Relationship to Investigational Drug
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0439849
Descripción
If 'Yes' record details in the Concomitant Medication section
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Descripción
Was patient withdrawn due to this specific AE?
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1518404
Descripción
Investigator's Signature (Adverse Experience)
Alias
- UMLS CUI-1
- C2346576
- UMLS CUI-2
- C0877248
Similar models
Laboratory Reference Ranges; Concomitant Medication; Adverse Experiences (Non-serious)
C0019994 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0022877 (UMLS CUI [1,2])
C0079399 (UMLS CUI [1,2])
C1514721 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,2])
C2697889 (UMLS CUI [2])
C0750729 (UMLS CUI [1,2])
C0205267 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0877248 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
Sin comentarios